Name of organisation
1) Department/Research groupPharmacoepidemiology and Pharmacovigilance department
2) Organisation/affiliationSpanish Agency of medicines and medical devices
Short Name in the inventoryAEMPS
Administrative Contact
Title Dr
Last name Montero
First name Dolores
Address line 1Parque Empresarial Las Mercedes
Address line 2C/Campezo 1 edificio 8
Address line 3
CityMadrid
Postcode28022
CountrySpain
Phone number (incl. country code)+34918225335
Alternative phone number
Fax number (incl. country code)
Scientific Contact
Title Dr
Last name Montero
First name Dolores
Address line 1Parque Empresarial Las Mercedes
Address line 2C/Campezo 1 edificio 8
Address line 3
CityMadrid
Postcode28022
CountrySpain
Phone number (incl. country code)+34918225335
Alternative phone number
Fax number (incl. country code)
Alternative Scientific Contact
Title Dr
Last name Maciá
First name Miguel Angel
Address line 1Parque Empresarial Las Mercedes
Address line 2C/Campezo 1 edificio 8
Address line 3
CityMadrid
Postcode28022
CountrySpain
Phone number (incl. country code)+34918225315
Alternative phone number
Fax number (incl. country code)
2. Description
The Spanish agency of medicines and medical devices (AEMPS) is a public body which belongs to the Ministry of Health. Its main task is to regulate all aspects of human and veterinary medicines, from authorisation to pharmacovigilance, so that marketed medicines have guarantees of efficacy, quality and safety.
Regarding pharmacovigilance, the Agency has developed and currently maintains BIFAP, a population based database containing general practitioner’s anonymised clinical records to perform pharmacoepidemiological studies. BIFAP database currently contains clinical records of more than 9 million patients. The AEMPS also is the coordinating centre for the Spontaneous Reporting Scheme in Spain and also administer the database supporting this program (FEDRA).
3. Category
Government based
Charity or non-profit organisation
4. Available resources
In houseVia Contacts/Network
Epidemiologist/Pharmacoepidemiologist
Yes
No
Statistician
Yes
No
Clinician
Yes
No
Clinical Pharmacologist
Yes
No
Pharmacist
Yes
No
Geneticist/Pharmacogeneticist
No
Yes
IT specialist
Yes
No
Ethics expertise
Yes
No
Legal expertise
Yes
No
Regulatory expertise
Yes
No
5. Therapeutic/disease areas of research in drug safety/risk-benefit performed in the past 5 years
Cardiovascular diseases
Disorders of the central nervous system
Endocrine disorders
Gastrointestinal tract
Geriatrics
Immunological products and vaccines
Infectious diseases
Liver disease
Malignant disease
Musculoskeletal and joint diseases
Osteoporosis
Paediatrics
Renal impairment
Respiratory diseases
Skin disorders
Urinary tract disorders
6. Design of drug safety/risk-benefit studies published in the past 5 years
Cohort Study
Case Control Study
Drug Utilisation
Meta-Analysis
7. Experience in collecting data directly from individual patients/respondents
None
8. Access to data collection resources
Capacity to conduct face-to-face interviews
No
Electronic data capture systems
Yes
System used:
Electronic medical records GP based. BIFAP Database
Interactive voice response systems
No
Call centre
No
9. Experience in secondary research and meta-analysis
Yes
10. Work with existing data resources in the past 3 years
Name of data resourceNo. of studies
BIFAP database30
11. Registries established by centre
Drug RegistryElectronic medical records. BIFAP database
Disease RegistryElectronic medical records. BIFAP database
12. Experience in collaboration in a study team
Principal Investigator
Collaborating Investigator
13. Current involvement in research networks
Other networks:
Network nameNationalInternationalLink to webpage